Full Coverage

Dr. Roy Altman Joins BioChemics Scientific Advisory Board to Advise on Clinical Development of...

May 7, 2008
Story Timeline:  212 days

News source: Business Wire BioChemics, Inc., a company "pioneering transdermal drug delivery," is pleased to announce that Dr. Roy D. Altman, Professor of Medicine, Division of Rheumatology and Immunology at the University of California, Los Angeles and Past President of... [read full story]                    

Add Comment
Latest article on this story:

Dr. Roy Altman Joins BioChemics Scientific Advisory Board to Advise on Clinical Development of...

redorbit.com May 7, 2008
First article on this story:

Dr. Roy Altman Joins BioChemics Scientific Advisory Board to Advise on Clinical Development of...

redorbit.com May 7, 2008
Selected publications with coverage of this story:
RELATED